Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
Michael Serpell,1 Mark Latymer,2 Mary Almas,3 Marie Ortiz,4 Bruce Parsons,4 Rita Prieto5 1University Department of Anaesthesia, Stobhill Ambulatory Care Hospital, Glasgow, 2Pfizer Ltd, Tadworth, UK; 3Pfizer, Groton, CT, 4Pfizer, New York, NY, USA; 5Pfizer GEP SLU, Madrid, Spain Background: Pregabali...
Main Authors: | Serpell M, Latymer M, Almas M, Ortiz M, Parsons B, Prieto R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-07-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/neuropathic-pain-responds-better-to-increased-doses-of-pregabalin-an-i-peer-reviewed-article-JPR |
Similar Items
-
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
by: Paolo Marchettini, et al.
Published: (2005-05-01) -
Fixed dose combination of low dose pregabalin and duloxetine, or pregabalin monotherapy for neuropathic pain: A double-blind, randomized, parallel-group study [version 1; peer review: 2 approved]
by: Sunil Dutt, et al.
Published: (2023-03-01) -
Duloxetine and pregabalin in neuropathic pain of lung cancer patients
by: Şule Karabulut Gül, et al.
Published: (2020-03-01) -
Pregabalin and amitriptyline as monotherapy or as low-dose combination in patients of neuropathic pain: A randomized, controlled trial to evaluate efficacy and safety in an Eastern India teaching hospital
by: Sourav Chakrabarty, et al.
Published: (2019-01-01) -
Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
by: Yohei Shimada, et al.
Published: (2017-01-01)